Diagnostic Approach to Splenomegaly

Initial Evaluation

The American College of Physicians recommends beginning with abdominal ultrasound to confirm splenomegaly, followed by CBC with differential, peripheral blood smear, comprehensive metabolic panel, and LDH, as splenomegaly greater than 13cm is clinically significant and warrants aggressive workup 1, 2, 3
Abdominal ultrasound is the first-line imaging modality to confirm splenomegaly, assess for focal lesions, evaluate liver size and appearance, and identify lymphadenopathy, with a sensitivity of 93% but only 57% specificity for detecting splenomegaly 1, 2, 3

Complete blood count with differential should be performed to identify cytopenias, leukocytosis, lymphocytosis, or abnormal cell populations suggesting hematologic malignancy 1, 2, 3
Peripheral blood smear review is critical to identify blasts, atypical lymphocytes, or other abnormal cells suggestive of leukemia or lymphoma 1, 2, 3
Comprehensive metabolic panel should be assessed to evaluate liver function, as liver disease is one of the three most common causes of splenomegaly in the United States 1, 2, 3
Lactate dehydrogenase (LDH) should be screened for hemolysis or malignancy 1, 3

Flow cytometry of peripheral blood for immunophenotyping should be performed immediately if lymphoproliferative disorder is suspected based on CBC findings 1, 2, 3
Testing for JAK2, CALR, and MPL mutations should be performed if myeloproliferative neoplasm is suspected, particularly with leukocytosis, thrombocytosis, or unexplained splenomegaly 1, 2, 3
Bone marrow aspiration and biopsy with immunohistochemistry, cytogenetics, and molecular testing is indicated when abnormal cells are found in peripheral blood, unexplained cytopenias are present, or myeloproliferative or lymphoproliferative disorder is suspected 1, 2, 3

CT or MRI of the abdomen should be obtained if ultrasound findings are equivocal, lymphadenopathy needs characterization, or focal splenic lesions are present 1, 3

Disseminated intravascular coagulation panel (D-dimer, fibrinogen, PT, PTT) should be performed in acute presentations, particularly when acute leukemia is suspected 1
Tumor lysis syndrome panel (uric acid, potassium, phosphates, calcium) should be performed when malignancy is suspected 1
Prothrombotic workup including JAK2 V617F mutation, paroxysmal nocturnal hemoglobinuria testing (CD55/CD59 flow cytometry), and inherited thrombophilias should be performed if portal vein thrombosis is identified 4

Immediate hematology referral is warranted for peripheral smear showing blasts or abnormal lymphocytes beyond typical reactive changes, presence of unexplained cytopenias, or symptomatic splenomegaly without clear etiology after initial workup 1, 2